RADIFY® for Chest
We’ve developed RADIFY® to enable radiologists to diagnose more images, more consistently and in less time – whilst prioritising care for people who need it most.
RADIFY® for Chest: Paediatric
Our AI tool for paediatric chest X-rays is a testament to our commitment to advancing healthcare through cutting-edge technology. We are dedicated to supporting healthcare providers in delivering the best possible care to our youngest patients.
Above is an image of a patient with known covid19 pneumonia. Multifocal consolidation detected by RADIFY.
RADIFY® use Case 1
A chest X-Ray is the first line of investigation for pneumonia. It’s the most readily available, quick and cost-effective imaging tool for the diagnosis of pneumonia – the number one killer of patients with COVID-19 and TB.
RADIFY® detects 25 major abnormalities on chest X-rays – including TB and COVID-19 pneumonia-related pathologies. It can label and prioritize over 2000 x-rays per minute.
A 76-year-old male presented with chest pain and dyspnoea. Patchy infiltrates in the right and left upper zones with air space opacification noted in the right midzone and left lower zone. RADIFY® has detected the lesions with bounding boxes in the region of interest. Result: High probability of pneumonia
Worldwide, TB is one of the top 10 causes of death and the leading cause from a single infectious agent (above HIV/AIDS)
A total of 1.4 million people died from TB in 2019
including 208 000 people with HIV
RADIFY® for TB
In 2019, an estimated 10 million people fell ill with tuberculosis (TB) worldwide, of which, 1.2 million where children, yet TB is curable and preventable.
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in 2019, according to preliminary data compiled by the World Health Organization (WHO) from over 80 countries- a reduction of 21% from 2019. The countries with the biggest relative gaps were Indonesia (42%), South Africa (41%), Philippines (37%) and India (25%). RADIFY® for TB , identifies pathologies on chest x-rays and triages the patients with high, intermediate and low probability of TB in children and adults. WHO now recommends CAD with chest x-rays to fight tuberculosis!
RADIFY® use Case 2
A 10 year old child with high probability of Tuberculosis detected by RADIFY®. Bilateral lymphadenopathy and bi-basal areas of confluent consolidation highlighted by RADIFY®.
- Use to prioritise scans during case overload.
- Use with portable x-ray machines to monitor progress of symptoms at point of care.
- Use when regular monitoring is required among patients showing mild symptoms, in order to identify and/or triage patients by the progression of symptoms.
Head Office: United Kingdom – Coveham House, Downside Bridge Road, Cobham, KT11 3 EP
South African Office: One-on Jameson Building, 1 Jameson Ave, Melrose Estate, Jhb, 2196
© 2023, Envisionit Deep AI (Pty) Ltd. 2019/038117/07. All Rights Reserved. Terms & Conditions apply.